Vergoeding 2019-2023 voor ATC-subgroep L04AX : Overige immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L04AX01 Azathioprine (Imuran ®) | 2.018.500 | 1.901.900 | 1.713.800 | 1.637.600 | 1.669.800 |
| L04AX03 Methotrexaat (Injexate ®) | 21.885.800 | 21.861.800 | 20.240.900 | 19.127.400 | 18.437.200 |
| L04AX05 Pirfenidon (Esbriet ®) | 10.306.500 | 10.670.100 | 10.045.200 | 11.031.700 | 10.041.600 |
| L04AX07 Dimethylfumaraat (Skilarence ®) | 48.706.500 | 51.348.100 | 51.535.400 | 52.725.500 | 47.530.400 |
| L04AX09 Diroximelfumaraat (Vumerity ®) | . | . | . | 2.095.200 | 5.568.900 |
| Totaal | 82.917.300 | 85.781.900 | 83.535.300 | 86.617.400 | 83.247.900 |